Actinium Pharmaceuticals, Inc. - FORM 10-K - EX-23.1 - ACCOUNTANT'S CONSENT - March 16, 2015

Attached files

file filename
EX-21.1 - LIST OF SUBSIDIARIES - Actinium Pharmaceuticals, Inc.f10k2014ex21i_actinium.htm
EX-32.1 - CERTIFICATION - Actinium Pharmaceuticals, Inc.f10k2014ex32i_actinium.htm
EX-31.1 - CERTIFICATION - Actinium Pharmaceuticals, Inc.f10k2014ex31i_actinium.htm
EX-32.2 - CERTIFICATION - Actinium Pharmaceuticals, Inc.f10k2014ex32ii_actinium.htm
EX-31.2 - CERTIFICATION - Actinium Pharmaceuticals, Inc.f10k2014ex31ii_actinium.htm
EX-3.7 - CERTIFICATE OF AMENDMENT - Actinium Pharmaceuticals, Inc.f10k2014ex3vii_actinium.htm
EX-10.42 - ACTINIUM PHARMACEUTICALS, INC. AMENDED AND RESTATED 2013 STOCK PLAN. - Actinium Pharmaceuticals, Inc.f10k2014ex10xlii_actinium.htm
EX-10.44 - ACTINIUM PHARMACEUTICALS, INC. AMENDED AND RESTATED 2013 EQUITY INCENTIVE PLAN. - Actinium Pharmaceuticals, Inc.f10k2014ex10xliv_actinium.htm
EX-10.43 - CONSULTING AGREEMENT - Actinium Pharmaceuticals, Inc.f10k2014ex10xliii_actinium.htm
EXCEL - IDEA: XBRL DOCUMENT - Actinium Pharmaceuticals, Inc.Financial_Report.xls
10-K - ANNUAL REPORT - Actinium Pharmaceuticals, Inc.f10k2014_actiniumpharma.htm

Exhibit 23.1

 

Consent of Independent Registered Public Accounting Firm

 

We consent to the incorporation by reference in the Registration Statement on Form S-3 (File No. 333-194768) and Form S-8 (File No. 333-197283) filed with the Securities and Exchange Commission, of our report dated March 16, 2015, relating to the consolidated financial statements of Actinium Pharmaceuticals, Inc. as of December 31, 2014 and 2013 and for the years then ended and relating to the internal controls over financial reporting for the year ended December 31, 2014, appearing in this Annual Report on Form 10-K of Actinium Pharmaceuticals, Inc.

 

/s/ GBH CPAs, PC

 

GBH CPAs, PC

www.gbhcpas.com

Houston, Texas

 

March 16, 2015

 

Actinium Pharmaceuticals, Inc. Reports